Incyte Corporation
INCY
$105.98
$0.780.74%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.81B | 4.58B | 4.41B | 4.24B | 4.08B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.81B | 4.58B | 4.41B | 4.24B | 4.08B |
| Cost of Revenue | 2.05B | 2.10B | 2.73B | 2.71B | 2.71B |
| Gross Profit | 2.77B | 2.49B | 1.68B | 1.53B | 1.37B |
| SG&A Expenses | 1.31B | 1.29B | 1.24B | 1.22B | 1.19B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.55B | 3.59B | 4.17B | 4.13B | 4.06B |
| Operating Income | 1.26B | 997.97M | 241.22M | 115.95M | 20.21M |
| Income Before Tax | 1.59B | 1.26B | 314.66M | 316.63M | 273.86M |
| Income Tax Expenses | 399.65M | 391.58M | 293.39M | 284.02M | 241.38M |
| Earnings from Continuing Operations | 1.19K | 870.87 | 21.27 | 32.62 | 32.48 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.19B | 870.87M | 21.27M | 32.62M | 32.48M |
| EBIT | 1.26B | 997.97M | 241.22M | 115.95M | 20.21M |
| EBITDA | 1.36B | 1.09B | 334.78M | 209.10M | 111.99M |
| EPS Basic | 6.11 | 4.50 | 0.37 | 0.31 | 0.17 |
| Normalized Basic EPS | 4.41 | 3.56 | 1.32 | 0.90 | 0.57 |
| EPS Diluted | 5.97 | 4.40 | 0.32 | 0.27 | 0.14 |
| Normalized Diluted EPS | 4.30 | 3.49 | 1.27 | 0.87 | 0.55 |
| Average Basic Shares Outstanding | 776.53M | 773.49M | 797.67M | 828.44M | 859.51M |
| Average Diluted Shares Outstanding | 795.79M | 790.20M | 809.63M | 838.66M | 867.36M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |